Clinical Trial Update: UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients [Phase 1]

View source ↗

Summary

A Phase 1 UC-MSC cell therapy trial for systemic lupus erythematosus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• UC-MSC cell therapy (umbilical cord-derived mesenchymal stem cells)

Snippet

Sponsor: LiveKidney.Bio | Conditions: SLE, Lupus | Phase 1 | Status: RECRUITING